‌

US Patent 10829481 Benzimidazole derivatives as modulators of ROR-gamma

Patent 10829481 was granted and assigned to Vitae Pharmaceuticals on November, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Vitae Pharmaceuticals

Current Assignee

Vitae Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10829481

Date of Patent

November 10, 2020

Patent Application Number

16073503

Date Filed

January 27, 2017

Patent Citations

‌

US Patent 10087184 Dihydropyrrolopyridine inhibitors of RORγ

‌

US Patent 10047085 Dihydropyrrolopyridine inhibitors of ROR-gamma

Patent Citations Received

‌

US Patent 11535614 Dihydropyrrolopyridine inhibitors of ROR-gamma

Patent Primary Examiner

‌

Alicia L Otton

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10829481 Benzimidazole derivatives as modulators of ROR-gamma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API